Overview
Availability
- Associate Professor David Wyld is:
- Available for supervision
Works
Search Professor David Wyld’s works on UQ eSpace
2016
Conference Publication
Unplanned admissions to a medical oncology unit at a tertiary hospital - an analysis of emergency presentations
Gunawan, Ben, Button, Elise, Bates, Tracey, Nasato, Gillian and Wyld, David (2016). Unplanned admissions to a medical oncology unit at a tertiary hospital - an analysis of emergency presentations. COSA's 43 and ANZBCTG's 38 Annual Scientific Meetings. Partners for Progress in Breast Cancer Research and Care, Gold Coast, QLD Australia, 15-17 November 2016. Chichester, West Sussex United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.12646
2016
Conference Publication
Pretherapy Identification of Patients at Risk of Receiving a High Renal Dose Undergoing Peptide Receptor Radionuclide Therapy
Goodman, S., Smith, J., Kumar, Ravi A., Wyld, D. and Burge, M. (2016). Pretherapy Identification of Patients at Risk of Receiving a High Renal Dose Undergoing Peptide Receptor Radionuclide Therapy. 13th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona, Spain, Mar 09-11, 2016. Basel, Switzerland: S. Karger AG. doi: 10.1159/000448725
2016
Conference Publication
A systematic review and meta-analysis of patient reporting outcomes in clinical practice
Roberts, Natasha, Janda, Monika, Alexander, Kimberley and Wyld, David (2016). A systematic review and meta-analysis of patient reporting outcomes in clinical practice. COSA's 43rd and ANZBCTG's 38th Annual Scientific Meetings. Partners for Progress in Breast Cancer Research and Care, Gold Coast, Australia, 15–17 November 2016. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.12635_4
2016
Conference Publication
Optimizing adjuvant chemotherapy delivery in older women with breast cancer - a review
Kalas, Timothy S. and Wyld, David (2016). Optimizing adjuvant chemotherapy delivery in older women with breast cancer - a review. COSA's 43 and ANZBCTG's 38 Annual Scientific Meetings. Partners for Progress in Breast Cancer Research and Care, Gold Coast International Hotel, Gold Coast, Queensland, Australia,, Gold Coast, QLD Australia. Chichester, West Sussex United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.12646
2016
Conference Publication
A Single Centres Experience of Cardiac Metastasis from Neuroendocrine Tumours (NET)
Ladwa, R., Burge, M. and Wyld, D. (2016). A Single Centres Experience of Cardiac Metastasis from Neuroendocrine Tumours (NET). 13th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona, Spain, Mar 09-11, 2016. Basel, Switzerland: S. Karger AG. doi: 10.1159/000448725
2016
Conference Publication
A prospective 2-year experience of a medical oncology advanced trainee in Queensland
Ladwa, Rahul, Chern, Boris, Sanmugarajah, Jasotha and Wyld, David (2016). A prospective 2-year experience of a medical oncology advanced trainee in Queensland. COSA's 43 and ANZBCTG's 38 Annual Scientific Meetings. Partners for Progress in Breast Cancer Research and Care, Gold Coast, QLD Australia, 15-17 November 2016. Chichester, West Sussex United Kingdom: Wiley-Blackwell Publishing.
2016
Journal Article
RAD51B in familial breast cancer
Pelttari, Liisa M., Khan, Sofia, Vuorela, Mikko, Kiiski, Johanna I., Vilske, Sara, Nevanlinna, Viivi, Ranta, Salla, Schleutker, Johanna, Winqvist, Robert, Kallioniemi, Anne, Dörk, Thilo, Bogdanova, Natalia V., Figueroa, Jonine, Pharoah, Paul D. P., Schmidt, Marjanka K., Dunning, Alison M., García-Closas, Montserrat, Bolla, Manjeet K., Dennis, Joe, Michailidou, Kyriaki, Wang, Qin, Hopper, John L., Southey, Melissa C., Rosenberg, Efraim H., Fasching, Peter A., Beckmann, Matthias W., Peto, Julian, Dos-Santos-silva, Isabel, Sawyer, Elinor J. ... Zeps, N. (2016). RAD51B in familial breast cancer. PLoS One, 11 (5) e0153788, e0153788. doi: 10.1371/journal.pone.0153788
2016
Journal Article
Hope, optimism and survival in a randomised trial of chemotherapy for metastatic colorectal cancer
Schofield, Penelope E., Stockler, M. R., Zannino, D., Tebbutt, N. C., Price, T. J., Simes, R. J., Wong, N., Pavlakis, N., Ransom, D., Moylan, E., Underhill, C., Wyld, D., Burns, I., Ward, R., Wilcken, N. and Jefford, M. (2016). Hope, optimism and survival in a randomised trial of chemotherapy for metastatic colorectal cancer. Supportive Care in Cancer, 24 (1), 401-408. doi: 10.1007/s00520-015-2792-8
2016
Conference Publication
The Difficulties of Response Assessment after Peptide Receptor Radionucleotide Therapy (PRRT): An Unusual Case of Symptomatic Pseudoprogression
Ladwa, R., Lyle, M., Wyld, D. and Burge, M. (2016). The Difficulties of Response Assessment after Peptide Receptor Radionucleotide Therapy (PRRT): An Unusual Case of Symptomatic Pseudoprogression. 13th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona, Spain, Mar 09-11, 2016. Basel, Switzerland: S. Karger AG. doi: 10.1159/000448725
2015
Journal Article
High-throughput amplicon-based copy number detection of 11 genes in formalin-fixed paraffin-embedded ovarian tumour samples by MLPA-seq
Kondrashova,Olga, Love, Clare J., Lunke, Sebastian, Hsu, Arthur L., Waring, Paul M., Taylor, Graham R., Australian Ovarian Cancer Study (AOCS) Group, Chenevix-Trench, G. and Wyld, D. (2015). High-throughput amplicon-based copy number detection of 11 genes in formalin-fixed paraffin-embedded ovarian tumour samples by MLPA-seq. PLoS One, 10 (11) e0143006, 1-14. doi: 10.1371/journal.pone.0143006
2015
Journal Article
A prospective study of the impact of fluorodeoxyglucose positron emission tomography with concurrent non-contrast CT scanning on the management of operable pancreatic and peri-ampullary cancers
Burge, Matthew E., O'Rourke, Nick, Cavallucci, David, Bryant, Richard, Francesconi, Alessandra, Houston, Kathleen, Wyld, David, Eastgate, Melissa, Finch, Robert, Hopkins, George, Thomas, Paul and Macfarlane, David (2015). A prospective study of the impact of fluorodeoxyglucose positron emission tomography with concurrent non-contrast CT scanning on the management of operable pancreatic and peri-ampullary cancers. HPB, 17 (7), 624-631. doi: 10.1111/hpb.12418
2015
Journal Article
A tsunami of unmet needs: pancreatic and ampullary cancer patients' supportive care needs and use of community and allied health services
Beesley, Vanessa L., Janda, Monika, Goldstein, David, Gooden, Helen, Merrett, Neil D., O'Connell, Dianne L., Rowlands, Ingrid J., Wyld, David and Neale, Rachel E. (2015). A tsunami of unmet needs: pancreatic and ampullary cancer patients' supportive care needs and use of community and allied health services. Psycho-Oncology, 25 (2), 150-157. doi: 10.1002/pon.3887
2015
Journal Article
Describing patterns of care in pancreatic cancer a population-based study
Burmeister, Elizabeth A., O'Connell, Dianne L., Beesley, Vanessa L., Goldstein, David, Gooden, Helen M., Janda, Monika, Jordan, Susan J., Merrett, Neil D., Payne, Madeleine E., Wyld, David and Neale, Rachel E. (2015). Describing patterns of care in pancreatic cancer a population-based study. Pancreas, 44 (8), 1259-1265. doi: 10.1097/MPA.0000000000000384
2015
Conference Publication
A randomised phase 3 trial of accelerated versus standard BEP chemotherapy for patients with intermediate and poor-risk metastatic germ cell tumours: the P3BEP Trial (Anzup 1302)
Lawrence, Nicola, Toner, Guy, Martin, Andrew, Stockler, Martin, Yeung, Annie, Wong, Nicole, Thomson, Damien, Gebski, Val, Yip, Sonia, King, Madeleine, Friedlander, Michael, Quinn, David, Tan, Thean Hsiang, Chan, Howard, Hanning, Fritha, Weickhardt, Andrew, Jeffery, Mark, Stevanovic, Amanda, Hovey, Elizabeth, Wyld, David, Davis, Ian and Grimison, Peter (2015). A randomised phase 3 trial of accelerated versus standard BEP chemotherapy for patients with intermediate and poor-risk metastatic germ cell tumours: the P3BEP Trial (Anzup 1302). COSA’s 42nd Annual Scientific Meeting. Rare Cancers: Common Goals, Hobart, Australia, 17–19 November 2015. Chichester, United Kingdom: Wiley-Blackwell. doi: 10.1111/ajco.12432_2
2015
Conference Publication
Efficacy of PRRT in metastatic neuroendocrine tumors; a retrospective large single institutional study
Jan, H., Wyld, D. and Burge, M. (2015). Efficacy of PRRT in metastatic neuroendocrine tumors; a retrospective large single institutional study. 12th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona Spain, Mar 11-13, 2015. Basel, Switzerland: S. Karger AG. doi: 10.1159/000431385
2015
Conference Publication
Experiences of Uncertainty and Invisibility: Women's Accounts of Living with a Rare Cancer
Wyld, David, Gibson, Alexandra, Broom, Alex, Plage, Stefanie, Cubitt, Annette and Lwin, Zarnie (2015). Experiences of Uncertainty and Invisibility: Women's Accounts of Living with a Rare Cancer. COSA’s 42nd Annual Scientific Meeting. Rare Cancers, Hobart, TAS, Australia, 17-19 November 2015. Chichester, West Sussex, United Kingdom: Wiley-Blackwell. doi: 10.1111/ajco.12432_2
2015
Conference Publication
A case of pulmonary carcinoid in pregnancy and review of carcinoid tumours in pregnancy
Kevat, D., Chen, M., Wyld, D., Fagermo, N. and Lust, K. (2015). A case of pulmonary carcinoid in pregnancy and review of carcinoid tumours in pregnancy. RCOG World Congress 2015, 12–15 April, Brisbane, Queensland, Australia, Brisbane, Queensland, Australia, 12–15 April 2015. Chichester, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/1471-0528.13370
2015
Conference Publication
Patient understanding of research in a medical oncology setting
Roberts, Natasha, Ives, Amy, Wyld, David and Cubitt, Annette (2015). Patient understanding of research in a medical oncology setting. COSA’s 42nd Annual Scientific Meeting. Rare Cancers: Common Goals, Hobart, Australia, 17–19 November 2015. Chichester, United Kingdom: Wiley-Blackwell. doi: 10.1111/ajco.12432_2
2015
Conference Publication
A Phase II Study of Everolimus in patients with FDG-PET positive intermediate grade (Ki67 3-20%) pancreatic neuroendocrine tumor
Michael, M., Pavlakis, N., Wyld, D., Link, E., Liauw, W., Kuru, N. and Hicks, R. (2015). A Phase II Study of Everolimus in patients with FDG-PET positive intermediate grade (Ki67 3-20%) pancreatic neuroendocrine tumor. 12th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona, Spain, March 11-13, 2015. Basel, Switzerland: S. Karger AG. doi: 10.1159/000431385
2014
Journal Article
Quality of life and treatment response among women with platinum-resistant versus platinum-sensitive ovarian cancer treated for progression: a prospective analysis
Beesley, Vanessa L., Green, Adele C., Wyld, David K., O'Rourke, Peter, Wockner, Leesa F., Defazio, Anna, Butow, Phyllis N., Price, Melanie A., Horwood, Keith R., Clavarino, Alexandra M. and Webb, Penelope M. (2014). Quality of life and treatment response among women with platinum-resistant versus platinum-sensitive ovarian cancer treated for progression: a prospective analysis. Obstetrical and Gynecological Survey, 69 (5), 257-259. doi: 10.1097/01.ogx.0000450117.94530.01
Supervision
Availability
- Associate Professor David Wyld is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Supervision history
Completed supervision
-
2020
Master Philosophy
Predictors of dosimetry and outcome to peptide receptor radionuclide therapy in metastatic neuroendocrine tumour.
Principal Advisor
Other advisors: Associate Professor David Pattison
-
2021
Doctor Philosophy
Targeting receptor activator of NF-kB pathways in combination immunotherapy
Associate Advisor
Media
Enquiries
For media enquiries about Associate Professor David Wyld's areas of expertise, story ideas and help finding experts, contact our Media team: